Citation Impact
Citing Papers
The Chicago Classification of esophageal motility disorders, v3.0
2014 Standout
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Human granulocytes undergo cell death via autophagy
2018
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Psoriasis
2021 Standout
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Achalasia Cardia Subtyping by High-Resolution Manometry Predicts the Therapeutic Outcome of Pneumatic Balloon Dilatation
2011
Fusobacterium nucleatumand colorectal cancer: A review
2018
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Global burden of liver disease: 2023 update
2023 Standout
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinoma
2011
Gastric cancer
2020 Standout
Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
2013
A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)
2013
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
2017
Hepatocellular carcinoma
2022 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Clinical Consequences of Infection in Cirrhosis: Organ Failures and Acute‐on‐Chronic Liver Failure
2019
Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance
2017
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Effect of Fluoroquinolone Resistance on 14‐day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy
2013
Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers
2019
Surveillance for hepatocellular carcinoma
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Antibiotic prophylaxis in cirrhosis: Good and bad
2015
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis
2021
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
2021
Works of Wei‐Chen Tai being referenced
Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis
2014
Medical expenses in treating acute esophageal variceal bleeding
2016
Clinical Remission in Endoscope-Guided Pneumatic Dilation for the Treatment of Esophageal Achalasia: 7-Year Follow-up Results of a Prospective Investigation
2009
The Outcome of Prophylactic Intravenous Cefazolin and Ceftriaxone in Cirrhotic Patients at Different Clinical Stages of Disease after Endoscopic Interventions for Acute Variceal Hemorrhage
2013
Delay in Human Neutrophil Constitutive Apoptosis after Infection with Klebsiella pneumoniae Serotype K1
2017
Clinical Implications of Alpha-fetoprotein in Chronic Hepatitis C
2009
Associated factors in Streptococcus bovis bacteremia and colorectal cancer
2016
Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis
2018
Randomized Comparison of Two Nonbismuth-Containing Rescue Therapies for Helicobacter pylori
2011
Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community
2013
The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study
2012
Randomized Comparison of Two Non‐Bismuth‐Containing Second‐line Rescue Therapies for Helicobacter pylori
2012
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-LineHelicobacter pyloriEradication
2015